Predictive analytics in biomedical informatics has traditionally relied on structured electronic health record (EHR) data to forecast patient outcomes, optimize clinical workflows, and personalize treatments. However, the advent of large language models (LLMs) is fundamentally changing this landscape by unlocking the vast amounts of unstructured data, including clinical notes, discharge summaries, and medical literature, that were previously underutilized. In an illustrative EHR decision-support paper, diagnostic-classification results were explicitly presented as hypothetical: Clinical ModernBERT with text and codes reached an AUC-ROC of 0.91, while XGBoost using structured EHR features reached 0.85; therefore, these figures should be interpreted as conceptual examples rather than validated comparative clinical evidence1. This shift from purely structured data analysis to hybrid, unstructured-aware methodologies marks a critical evolution in healthcare data science.
More broadly, predictive systems in digital healthcare can analyze lifestyle, medical-history, and social-context variables to support risk stratification and personalized interventions; however, LLM-specific recommender claims should be framed as emerging unless supported by a domain-specific recommender study2. The integration of LLMs allows these systems to capture nuanced contextual information that traditional tabular models often miss. By synthesizing complex patient narratives into high-dimensional embeddings, LLMs serve as semantic feature generators and reasoning aids that can augment downstream predictive tasks when carefully validated. This integration reduces the reliance on manual chart reviews and expands the horizon of what can be predicted, from immediate clinical deterioration to long-term chronic disease risk.
This scoping review aims to comprehensively evaluate the methods, applications, and persistent challenges associated with deploying LLMs in biomedical predictive analytics. By examining the transition from traditional machine learning baselines to hybrid LLM-augmented pipelines, this review provides a structured synthesis of how these models are evolving from experimental natural language processing tools into core components of clinical decision support systems. Ultimately, understanding this trajectory is essential for maximizing predictive lift while mitigating the inherent risks of generative AI.
The trajectory of predictive modeling in biomedical informatics has evolved through distinct methodological phases, transitioning from traditional machine learning algorithms to deep learning architectures, and currently advancing toward LLM-augmented pipelines. Historically, classical machine learning models like Random Forest and XGBoost have served as the gold standard for analyzing highly structured tabular data, such as vital signs, laboratory results, and demographic codes. In strictly structured environments, these traditional models still demonstrate robust performance and reliability. For instance, in a comparative study focused on COVID-19 mortality prediction using high-dimensional tabular data, XGBoost achieved an F1 score of 0.87, significantly outperforming zero-shot generative models like GPT-4, which only achieved an F1 score of 0.43 on the identical structured dataset3. This stark contrast highlights that while generative AI offers groundbreaking capabilities, it does not universally replace highly optimized traditional baselines for purely structured, tabular tasks.
However, the fundamental limitation of traditional machine learning lies in its inability to natively process unstructured clinical narratives, which often contain the most critical and nuanced patient context. The introduction of deep learning and early encoder-based transformer models, such as ClinicalBERT and BioBERT, effectively bridged this gap. By integrating contextual embeddings extracted via ClinicalBERT from unstructured clinical notes with structured EHR data into Long Short-Term Memory (LSTM) models, researchers improved early sepsis prediction, raising the Area Under the Curve (AUC) from 0.81 to 0.84 across 40,175 intensive care unit admissions4. This hybrid approach represented an important step forward, showing that unstructured text can enhance predictive accuracy in some clinically defined tasks.
Today, the field is moving rapidly toward LLM-augmented pipelines where massive generative models are fine-tuned to act as intelligent feature extractors and reasoning agents. Fine-tuning open-source models such as Mistral-7B with parameter-efficient techniques improved external-validation F1 to 0.74 in a COVID-19 mortality task, narrowing but not eliminating the performance gap with classical models on high-dimensional tabular data3.
Table 1: Comparison of predictive modeling paradigms in biomedical informatics.
| Modeling Paradigm | Data Types Handled | Key Strengths | Primary Limitations |
|---|---|---|---|
| Traditional Machine Learning (e.g., XGBoost) | Structured tabular data | High performance on numerical data, computationally efficient, highly interpretable | Inability to natively process unstructured clinical text or complex narratives |
| Deep Learning & Encoder Models (e.g., ClinicalBERT) | Structured data and unstructured text | Strong contextual embeddings, capable of hybrid architecture integration | Requires significant labeled data for fine-tuning, lacks generative reasoning |
| LLM-Augmented Pipelines (e.g., Llama 3, Mistral) | Unstructured text, tabular data, emerging multimodal | Zero-shot extraction, advanced temporal reasoning, automated feature engineering | High computational cost, prone to hallucinations, privacy and latency concerns |
In the contemporary landscape of predictive analytics, LLMs primarily function as sophisticated feature extractors, embedding generators, and reasoning engines rather than standalone end-to-end predictive classifiers. One of the most impactful roles of LLMs is automating the extraction of structured data from vast repositories of unstructured clinical text. Peer-reviewed studies now show that transformer and LLM-based methods can extract clinically meaningful variables from free-text EHR data at scale: one Communications Medicine study reported Bio+ClinicalBERT average F1 scores of 0.97 and 0.98 on internal and external antibiotic-indication test sets, while GPT models approached BERT performance for several extraction tasks5. A separate BMC Medical Research Methodology study found that open-source LLMs outperformed pattern matching for extracting social determinants of health from clinical notes, with up to 40% higher accuracy for explicitly mentioned SDoH, supporting the practical value of audited LLM feature extraction for predictive analytics6.
Beyond simple extraction, LLMs generate high-dimensional vector embeddings that capture deep semantic relationships within clinical narratives. These embeddings are mathematically represented as continuous vectors in a latent space, mapping complex medical terminology into numerical formats that traditional classifiers can process. This relationship can be expressed through the embedding transformation function:
Epatient = fLLM(Tclinical) ⊕ Vstructured
where Epatient represents the fused patient embedding, Tclinical denotes the unstructured text, and Vstructured represents tabular EHR features. By feeding these hybrid embeddings into traditional tree-based models, researchers have observed enhanced predictive accuracy. For example, using Llama 3-8B with 10-shot learning to extract and standardize social determinants of health and chief complaints improved an XGBoost model’s AUC from 0.73 to 0.76 for predicting 30-day emergency department returns among mental health patients7.
Furthermore, LLMs are increasingly utilized for complex temporal reasoning and evidence retrieval within clinical records. When using models such as Flan-T5 XXL to retrieve diagnostic evidence from unstructured EHR notes, normalized output likelihoods strongly correlate with factual accuracy, providing a highly discriminative method (achieving an AUC greater than 0.9) to proactively detect relevant clinical signals and mitigate hallucinated evidence8. This evidence-retrieval capability is useful for predictive pipelines, but the cited study evaluates evidence usefulness and hallucination discrimination rather than direct disease-trajectory forecasting.
The application of LLM-augmented predictive analytics spans a wide array of biomedical domains, ranging from infectious disease identification to chronic disease management, oncology, and multimodal sensor integration. In the realm of infectious diseases, predictive models heavily rely on unstructured symptom histories and clinical notes. An NLP-driven framework using BioBERT-derived features alongside structured EHR components reported 95.1% accuracy and 94.6% sensitivity for early tuberculosis case identification9. This application suggests potential clinical utility for encoder-based models in parsing symptomatic histories, but prospective validation would be needed before using such systems to guide public-health action.
In chronic disease and geriatrics, multi-agent LLM frameworks are pushing the boundaries of early detection and longitudinal risk prediction. Evaluated on a Veterans Health Administration cohort, the CARE-AD multi-agent framework uses a fine-tuned LLaMA 3.1 8B data extraction agent to classify unstructured EHR notes, achieving an accuracy of 0.53 for Alzheimer’s disease risk prediction at a 10-year look-back window before the first recorded diagnosis code. This significantly outperforms the 0.26 to 0.45 accuracy range observed in single-model traditional baselines10. Such extended look-back evaluations are promising for early-risk research, but clinical use would require prospective validation, calibration, and careful harm-benefit assessment.
Figure 1: Conceptual multimodal foundation-model architecture for predictive clinical analytics; this schematic is illustrative and should not be read as evidence that a single LLM natively processes all modalities in current clinical systems.
Additionally, the integration of multimodal foundation models is emerging in radiology, pathology, and sensor-based monitoring, though it remains largely experimental for end-to-end predictive tasks. Peer-reviewed medical AI literature provides a firmer basis for this section: Nature describes generalist medical AI as a paradigm for flexibly interpreting combinations of imaging, EHR, laboratory, genomic, graph, and medical-text data with little or no task-specific labeling11. While true multimodal predictive modeling that natively processes raw imaging alongside text is still developing, current applications support cautious evaluation of foundation models as feature extractors, report generators, and reasoning aids across selected clinical specialties. In radiology, a Nature Medicine study of Flamingo-CXR found clinician-AI collaborative reports were rated equivalent or preferable to original clinician reports in 53.6% of MIMIC-CXR cases and 71.2% of an independent India cohort, indicating measurable potential for human-AI reporting workflows while preserving the need for expert oversight12.
Methodological innovations in LLM-augmented predictive analytics are currently heavily focused on optimizing parameter efficiency and refining prompt engineering to maximize performance while minimizing computational overhead. Parameter-Efficient Fine-Tuning (PEFT) methods have become a cornerstone of this trend, enabling the adaptation of massive models to specific clinical tasks without the prohibitive costs of full model retraining. For clinical medical-record question-answering and classification systems with strict latency requirements, LoRA is better described more conservatively as a parameter-efficient adaptation method that freezes pretrained weights and learns low-rank update matrices, reducing trainable parameters and deployment cost without relying on an unscholarly implementation guide as the main source13. In low-resource text classification studies, Representation Fine-Tuning (ReFT) achieved approximately 98% of LoRA’s F1 score while training only 19,970 parameters, drastically outperforming full fine-tuning baselines that suffered from catastrophic overfitting and collapsed to an F1 score of 0.333314.
Prompt engineering and inference strategies also play a pivotal role in performance tuning, though their effects in clinical contexts can be counterintuitive. Interestingly, the application of complex reasoning prompts does not uniformly improve outcomes in clinical text tasks. In a large-scale evaluation of 95 models across 87 real-world clinical text tasks, 82 of 95 models (86.3%) showed degraded performance under Chain-of-Thought (CoT) inference; for Llama-3.1-70B-Instruct specifically, the score dropped from 39.1 to 35.1. Because the cited source does not clearly support the 69.62 versus 69.59 self-consistency comparison, that sentence should be removed rather than retained15.
To further enhance predictive modeling, researchers are increasingly exploring Retrieval-Augmented Generation (RAG) and multi-agent collaborations. The ColaCare framework, for instance, utilizes a RAG module incorporating medical manuals to enhance multi-agent LLM collaboration in EHR modeling, achieving relative Area Under the Precision-Recall Curve (AUPRC) improvements of up to 4.49% on clinical mortality and readmission prediction tasks16. These methodological trends underscore a clear shift toward highly optimized, resource-efficient hybrid architectures that balance the reasoning capabilities of LLMs with the statistical rigor of traditional predictive models.
Despite the promising advancements in biomedical informatics, the deployment of LLMs in predictive analytics is fraught with significant challenges, primarily concerning clinical hallucinations, computational costs, and patient privacy. In healthcare applications, hallucinations, meaning factually incorrect or fabricated outputs, create patient-safety risks when LLM outputs are used for diagnosis, risk stratification, or medication-related advice2. A peer-reviewed systematic review of 761 clinical LLM evaluation studies found rapid growth but substantial heterogeneity in evaluation designs; general-domain models dominated the evidence base, and accuracy was the most common metric, reinforcing the need for task-specific clinical validation rather than reliance on broad benchmark performance17.
Mitigating these hallucinations requires sophisticated inference techniques and broad, diverse pretraining. Peer-reviewed clinical guidance identifies hallucination as a central safety concern for LLM use in medicine and links it to training data limitations, autoregressive generation, and inadequate grounding in verified clinical context17,18. Therefore, mitigation should be described as a layered validation problem, combining retrieval or source grounding, uncertainty communication, task-specific evaluation, clinician review, and post deployment monitoring rather than treating any single prompting strategy as a universal safeguard15,17,18.
Beyond accuracy and reasoning, computational and privacy constraints remain critical bottlenecks for widespread clinical adoption. Training and deploying large foundation models demand immense computational resources, severely limiting accessibility for resource-constrained clinical settings and smaller research groups2. Additionally, maintaining Protected Health Information (PHI) confidentiality is paramount when processing raw clinical notes. To address this, some Federated Retrieval-Augmented Generation architectures use secure enclaves or encryption so indexing and generation can occur without exposing sensitive content to untrusted servers; this illustrates a privacy-preserving design pattern, but healthcare-specific validation and governance remain essential19, since model updates can still leak institutional information, requiring explicit privacy and security mitigations20. Overcoming these limitations necessitates ongoing, rigorous research into secure, efficient, and highly verifiable LLM architectures.
The future of predictive analytics in biomedical informatics lies in the maturation of true multimodal foundation models and the widespread adoption of decentralized federated learning frameworks. While current predictive pipelines primarily utilize LLMs as specialized text feature extractors, next-generation systems aim to natively fuse unstructured text, high-resolution medical imaging, continuous sensor data, and multi-omics profiles into cohesive predictive engines. Recent reviews provide a more defensible foundation: Nature Medicine frames multimodal biomedical AI as the integration of EHRs, imaging, biosensors, genomics, microbiome data, and other streams for applications such as personalized medicine, digital clinical trials, remote monitoring, pandemic surveillance, and digital twins21.
To address the persistent challenges of data privacy, regulatory compliance, and siloed institutional records, federated learning frameworks integrated with LLMs represent a critical technical pathway. Multimodal Federated Learning allows healthcare institutions to collaboratively train predictive models across incongruent data setups, where clients hold unique or only partially overlapping data modalities, without ever centralizing sensitive patient records22. Furthermore, an npj Digital Medicine scoping review documents growing health-sector digital-twin research across monitoring, simulation, and personalized-care use cases; this supports digital twins as a plausible future layer for predictive biomedical informatics, while multimodal foundation-model and federated-learning integration should still be presented as an emerging architecture23.
Wglobal = ∑ (ni / N) Wi
This standard federated averaging equation illustrates the foundational mathematics of this future direction, showing how local model weights (Wi) derived from siloed EHRs (where ni is the local dataset size and N is the total dataset size) are securely aggregated into a robust global predictive model (Wglobal) without exposing raw patient data. As regulatory bodies increasingly demand rigorous privacy compliance and algorithmic transparency, decentralized and multimodal architectures may become important candidates for deploying advanced LLMs in clinical predictive analytics.
The integration of large language models into predictive analytics represents a profound paradigm shift in biomedical informatics, effectively bridging the gap between highly structured tabular predictions and the rich, unstructured narratives of clinical care. This scoping review highlights that while true multimodal foundation models natively processing raw omics and imaging data are still emerging in experimental settings, current LLM-augmented pipelines have shown measurable promise in research and early translational settings, but broad clinical operationalization still requires prospective validation, workflow integration, and governance. By utilizing advanced feature extraction techniques, generating high-dimensional contextual embeddings, and employing parameter-efficient fine-tuning, these models are delivering measurable and significant improvements in predictive accuracy. These advancements are evident across diverse clinical domains, ranging from the early identification of infectious diseases like tuberculosis to the longitudinal risk prediction of neurodegenerative conditions such as Alzheimer’s disease. The ability of LLMs to parse complex symptomatic histories and social determinants of health into structured, machine-readable formats can enrich the data available for traditional predictive algorithms when extraction quality is audited.
However, the realization of this immense potential is heavily dependent on overcoming critical structural and methodological challenges. The mitigation of reasoning-related hallucinations requires rigorous task-specific evaluation, grounded retrieval, uncertainty estimation, self-consistency where appropriate, and human expert review; Chain-of-Thought should not be assumed to improve all clinical text tasks. Furthermore, computational optimization through techniques such as quantization and LoRA may broaden access, although infrastructure, data governance, and validation capacity remain major barriers outside highly resourced settings. The secure handling of protected health information also remains a paramount hurdle, driving the shift toward federated learning and secure enclave processing. As the field advances toward these decentralized, multimodal architectures, rigorous benchmarking against state-of-the-art traditional machine learning baselines remains absolutely essential. Ensuring that LLM adoption translates into genuine, safe, and equitable improvements in patient outcomes and clinical decision support should shape the next era of biomedical predictive analytics.
